Zübeyir Elmazoğlu

479 total citations
30 papers, 373 citations indexed

About

Zübeyir Elmazoğlu is a scholar working on Pharmacology, Molecular Biology and Rheumatology. According to data from OpenAlex, Zübeyir Elmazoğlu has authored 30 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 5 papers in Molecular Biology and 5 papers in Rheumatology. Recurrent topics in Zübeyir Elmazoğlu's work include Osteoarthritis Treatment and Mechanisms (5 papers), Inflammatory mediators and NSAID effects (5 papers) and Aldose Reductase and Taurine (4 papers). Zübeyir Elmazoğlu is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (5 papers), Inflammatory mediators and NSAID effects (5 papers) and Aldose Reductase and Taurine (4 papers). Zübeyir Elmazoğlu collaborates with scholars based in Türkiye, United States and Mexico. Zübeyir Elmazoğlu's co-authors include Çi̇men Karasu, Ebru Alp, Sevda Menevşe, Abel Santamarı́a, Edgar Rangel‐López, Milan Štefek, Marta Šoltésová Prnová, Safacan Kölemen, Michael Aschner and Isaac Túnez and has published in prestigious journals such as Annals of the Rheumatic Diseases, Osteoarthritis and Cartilage and Toxicon.

In The Last Decade

Zübeyir Elmazoğlu

29 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zübeyir Elmazoğlu Türkiye 12 103 73 46 40 39 30 373
Mo‐Li Zhu China 16 207 2.0× 45 0.6× 86 1.9× 25 0.6× 17 0.4× 34 561
Caixia Chen China 12 161 1.6× 83 1.1× 29 0.6× 15 0.4× 18 0.5× 26 386
A Young Choi South Korea 5 172 1.7× 65 0.9× 50 1.1× 77 1.9× 26 0.7× 7 337
Ayşe Ercan Türkiye 14 206 2.0× 66 0.9× 73 1.6× 64 1.6× 31 0.8× 29 626
Baiping Cui China 13 159 1.5× 41 0.6× 88 1.9× 21 0.5× 12 0.3× 19 487
Ebru Bodur Türkiye 15 172 1.7× 131 1.8× 54 1.2× 20 0.5× 52 1.3× 38 589
Juan Hu China 11 208 2.0× 58 0.8× 54 1.2× 21 0.5× 18 0.5× 18 372
Ruixia Deng Hong Kong 11 181 1.8× 47 0.6× 44 1.0× 24 0.6× 15 0.4× 18 501
Shalini Mani India 14 244 2.4× 47 0.6× 88 1.9× 15 0.4× 55 1.4× 44 535

Countries citing papers authored by Zübeyir Elmazoğlu

Since Specialization
Citations

This map shows the geographic impact of Zübeyir Elmazoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zübeyir Elmazoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zübeyir Elmazoğlu more than expected).

Fields of papers citing papers by Zübeyir Elmazoğlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zübeyir Elmazoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zübeyir Elmazoğlu. The network helps show where Zübeyir Elmazoğlu may publish in the future.

Co-authorship network of co-authors of Zübeyir Elmazoğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Zübeyir Elmazoğlu. A scholar is included among the top collaborators of Zübeyir Elmazoğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zübeyir Elmazoğlu. Zübeyir Elmazoğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Elmazoğlu, Zübeyir, et al.. (2024). Protection against α-Amanitin-induced liver toxicity: Efficacy of pomegranate seed oil and black cumin oil. Toxicon. 247. 107854–107854. 1 indexed citations
3.
Keleş, Elif, et al.. (2024). Phthalate exposure induces cell death and ferroptosis in neonatal microglial cells. TURKISH JOURNAL OF MEDICAL SCIENCES. 54(5). 1102–1115. 3 indexed citations
4.
Elmazoğlu, Zübeyir, et al.. (2023). Melatonin effective to reduce the microscopic symptoms of polycystic ovary syndrome-related infertility: An experimental study. Tissue and Cell. 81. 102015–102015. 3 indexed citations
5.
Elmazoğlu, Zübeyir, et al.. (2022). Selective monitoring and treatment of neuroblastoma cells with hydrogen sulfide activatable phototheranostic agent. Dyes and Pigments. 210. 111011–111011. 12 indexed citations
6.
7.
Elmazoğlu, Zübeyir, Abel Santamarı́a, Edgar Rangel‐López, et al.. (2021). Platinum nanoparticles Protect Against Lipopolysaccharide-Induced Inflammation in Microglial BV-2 Cells via Decreased Oxidative Damage and Increased Phagocytosis. Neurochemical Research. 46(12). 3325–3341. 10 indexed citations
9.
Elmazoğlu, Zübeyir, et al.. (2020). Standardized extract of Olea europaea leaves suppresses pro-inflammatory cytokines through regulating redox signaling pathways in human chondrocytes. Osteoarthritis and Cartilage. 28. S105–S106. 1 indexed citations
10.
Elmazoğlu, Zübeyir, Candan Özoğul, Berna Göker, et al.. (2020). TLR4, RAGE, and p‐JNK/JNK mediated inflammatory aggression in osteoathritic human chondrocytes are counteracted by redox‐sensitive phenolic olive compounds: Comparison with ibuprofen. Journal of Tissue Engineering and Regenerative Medicine. 14(12). 1841–1857. 10 indexed citations
12.
Elmazoğlu, Zübeyir, Berna Göker, Berivan Bıtık, et al.. (2020). Colchicine provides chondrocyte survival as a redox modulator in human osteoarthritis. Osteoarthritis and Cartilage. 28. S105–S105. 2 indexed citations
13.
Elmazoğlu, Zübeyir, Marta Šoltésová Prnová, Abel Santamarı́a, Milan Štefek, & Çi̇men Karasu. (2020). Combatting Nitrosative Stress and Inflammation with Novel Substituted Triazinoindole Inhibitors of Aldose Reductase in PC12 Cells Exposed to 6-Hydroxydopamine Plus High Glucose. Neurotoxicity Research. 39(2). 210–226. 11 indexed citations
14.
Elmazoğlu, Zübeyir, Edgar Rangel‐López, Omar Noel Medina‐Campos, et al.. (2020). Cannabinoid-profiled agents improve cell survival via reduction of oxidative stress and inflammation, and Nrf2 activation in a toxic model combining hyperglycemia+Aβ1-42 peptide in rat hippocampal neurons. Neurochemistry International. 140. 104817–104817. 26 indexed citations
15.
Erdoğan, Deniz, et al.. (2019). Melatonin modulates nmda-receptor 2b/calpain-1/caspase-12 pathways in rat brain after long time exposure to gsm radiation. Turkish Neurosurgery. 29(6). 887–900. 6 indexed citations
16.
Prnová, Marta Šoltésová, Lucia Kováčiková, Karol Švík, et al.. (2019). Triglyceride-lowering effect of the aldose reductase inhibitor cemtirestat—another factor that may contribute to attenuation of symptoms of peripheral neuropathy in STZ-diabetic rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 393(4). 651–661. 20 indexed citations
17.
Prnová, Marta Šoltésová, Lucia Račková, Lucia Kováčiková, et al.. (2019). General toxicity assessment of the novel aldose reductase inhibitor cemtirestat. Interdisciplinary Toxicology. 12(3). 120–128. 11 indexed citations
19.
Rangel‐López, Edgar, Juana Villeda‐Hernández, Anahí Chavarría, et al.. (2018). The Pharmacological Inhibition of Fatty Acid Amide Hydrolase Prevents Excitotoxic Damage in the Rat Striatum: Possible Involvement of CB1 Receptors Regulation. Molecular Neurobiology. 56(2). 844–856. 25 indexed citations
20.
Alp, Ebru, et al.. (2016). Effect of API-1 and FR180204 on cell proliferation and apoptosis in human DLD-1 and LoVo colorectal cancer cells. Oncology Letters. 12(4). 2463–2474. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026